These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30444556)

  • 1. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
    Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
    Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
    Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
    Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
    Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
    Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
    Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
    Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for HIV positivity among more than 3,400 Tanzanian women.
    Faber MT; Munk C; Mwaiselage J; Dartell M; Kahesa C; Iftner T; Rasch V; Kjaer SK
    Women Health; 2017 Jul; 57(6):650-664. PubMed ID: 27379612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
    Mchome B; Swai P; Wu C; Katanga J; Kahesa C; Manongi R; Mwaiselage JD; Kjaer S; Rasch V; Linde DS
    BMJ Open; 2020 Sep; 10(9):e038531. PubMed ID: 32948569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
    Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
    Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.
    Jalil EM; Luz PM; Quintana M; Friedman RK; Madeira RMDS; Andrade AC; Chicarino J; Moreira RI; Derrico M; Levi JE; Russomano F; Veloso VG; Grinsztejn B
    Braz J Infect Dis; 2018; 22(1):16-23. PubMed ID: 29207280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.
    Toliman PJ; Kaldor JM; Badman SG; Gabuzzi J; Silim S; Kumbia A; Kombuk B; Kombati Z; Munnull G; Guy R; Vallely LM; Kelly-Hanku A; Wand H; Ryan C; Tan G; Brotherton J; Saville M; Mola GDL; Garland SM; Tabrizi SN; Vallely AJ
    Papillomavirus Res; 2018 Dec; 6():70-76. PubMed ID: 30391365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
    Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
    Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.